drugset / Trial / NCT01764776
Effect of Hepatic Impairment on LDE225..
NaSingle-groupOpen-labelTreatment
Summary
This study is to evaluate the pharmacokinetics and safety of 800 mg of LDE225 in subjects with impaired hepatic function and healthy subjects with normal hepatic function.
Timeline
- Start
- 2013-03
- Primary completion
- 2015-03
- Completion
- 2015-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sonidegib | Small molecule | 800 mg | — |
Indications
No indication recorded.